COR Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Cencora Inc. Stock Analysis COR
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. The company is headquartered in Conshohocken, Pennsylvania and currently employs 42,000 full-time employees. The firm helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The firm operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Read More COR Chart
Cencora Inc vs S&P 500 Comparative Returns
Analysis of COR stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Cencora Inc (COR) 30.38%
- S&P 500 -4.27%
Cencora Inc Outperformed S&P 500 by 34.65%
1Y Performance
- Cencora Inc (COR) 32.55%
- S&P 500 8.86%
Cencora Inc Outperformed S&P 500 by 23.69%
3Y Performance
- Cencora Inc (COR) 95.05%
- S&P 500 37.21%
Cencora Inc Outperformed S&P 500 by 57.84%
5Y Performance
- Cencora Inc (COR) 217.54%
- S&P 500 92.3%
Cencora Inc Outperformed S&P 500 by 125.24%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$293.58Volume
1.54MP/E Ratio (TTM)
36.0652 Week Range
Market Cap
55.43BAvg. Volume
1.86MDividend Yield
0.77%Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenue per Share (TTM) | 930.85 | 743.02 | 1158.19 | 1304.34 | 1507.91 |
EBIT per Share (TTM) | 9.92 | 9.29 | 13.55 | 12.6 | 15.59 |
Earnings per Share (EPS) (TTM) | - | - | - | 8 | 7 |
Dividend per Share (TTM) | 1.68 | 1.27 | 1.9 | 1.98 | 2.13 |
EPS Forward | -16.63 | 7.4 | 8.05 | 8.51 | 7.53 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Joel Greenblatt
% Portfolio:
0.08 Recent Activity:-38.15%
Jefferies Group
% Portfolio:
0.02 Recent Activity:61.61%
Richard Pzena
% Portfolio:
< 0.01 Recent Activity:100.00%
Ken Fisher
% Portfolio:
< 0.01 Recent Activity:17.69%

Community-Curated Collections ( With COR )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
Name | Price | 1D Change | Market Cap | Rating | |
---|---|---|---|---|---|
Mckesson CorpMCK | $719.19 | 0.99% | 88424 | Unlock | |
Patterson Companies IncPDCO | $31.33 | 0.03% | 2760 | Unlock | |
CS Diagnostics CorpFZRO | $3.10 | 58.97% | 357 | Unlock | |
W Wellgistics Health IncWGRX | $2.66 | 0.75% | 167 | Unlock | |
CS Diagnostics CorpCSDX | $0.09 | 3.53% | - | Unlock | |
BIMI Holdings IncBIMI | $0.00 | 0.00% | - | Unlock |